We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

SUBSCRIBE: Print / eNewsletter

International Group Preparing Guidelines for Antiemesis Agents

Nov 1, 2001
Volume: 
10
Issue: 
11
  • Nausea and Vomiting

NEW YORK—Members of eight major oncologic organizations are working
together to produce a set of uniform guidelines for the prevention and control
of nausea and vomiting in cancer patients undergoing chemotherapy.

The ad hoc international group is working to reconcile the six sets of
guidelines already issued by various professional organizations, according to
Richard Gralla, MD, associate director and professor of medicine, Herbert
Irving Comprehensive Cancer Center of Columbia University College of Medicine.

Broad Collaboration

The collaboration includes representatives of oncology nursing, pharmacy, and medical oncology, as well as of the Multinational
Society for Supportive Care in Cancer, Dr. Gralla said during an international
teleconference for health professionals sponsored by the European Association
for Cancer Education and Cancer Care, Inc.

Nurses’ Role in Antiemesis

Proper management of nausea and vomiting requires in-depth
knowledge of both risk factors and available treatments, said Jackie Green, RGN,
lead cancer nurse and senior nurse at the Hematology and Cancer Services, Kings
College Hospital NHS Trust Medical Care Group, London. She emphasized that a
personalized, detailed, multidimensional assessment of each patient is needed
to tailor an effective treatment plan.

"Nurses play the key role in the multidisciplinary team
because of their expertise in assessment and patient education," Dr.
Richard Gralla said. He added that good communication among team members is
crucial to providing the best possible treatment for each patient.

The international collaboration on guidelines aims to help in
this effort, he said. The group hopes that its efforts will result in simple,
clear tools such as standing orders and easy-to-use forms that will ease the
ordering of appropriate medications and assist nurses in administering them and
in educating patients and family members to use them correctly.

Dr. Gralla is one of about 20 individuals from the United States, Canada,
the United Kingdom, and Europe involved in the guidelines project. He said that
preliminary results have been presented at several meetings in the United
States and Europe, with the final document slated for submission for publication later this year.

When the guidelines are finalized, the group hopes to make them easily
available in such forms as laminated cards and files that can be downloaded
from the Internet.

Different countries now follow varying guidelines for prevention and
treatment of nausea and vomiting, although studies point to a single set of
effective approaches. The dosages of various agents currently being prescribed
vary widely, he observed. In addition, studies show that even existing
guidelines are often not followed.

Pages

  • 1
  • 2
  • next ›
  • last »

Related Articles

  • Rolapitant-Based Antiemetic Combination Improves CINV Symptoms
  • Combo Antiemetic Therapy Safe, Effective for Testicular Cancer Patients on Cisplatin Chemotherapy
  • Aprepitant Warrants More Study for CINV in Patients on FOLFOX for CRC
  • FDA Approves Rolapitant for Delayed CINV
  • Poor Adherence to Guidelines for Preventing Chemotherapy-Induced Nausea, Vomiting

Resource Topics rightRail

  • Resource Topics
  • Partner Content
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Melanoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

Oncology Vol 32 No 4
Apr 15, 2018 Vol 32 No 4
Digital Edition
Subscribe
Connect with Us
  • Twitter
  • Facebook
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.